You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.
RenovoDerm partners with SDVOSB RegeniSource to offer ANTHEM Wound Matrix Fenestrated for our Veterans and Military - May 2021 | Dr. Mark Melin speaks about pH and the value of PHOENIX Wound Matrix on the Frank & Lizzie Show - June 2021 | PHOENIX Wound Matrix will showcase its technology at SAWC Fall 2021 in Las Vegas. | Jed Johnson, CTO Nanofiber Solutions speaks about Emerging Technologies in Wound Healing at The American Vein and Lymphatic Society (AVLS) October 7-10, 2021 in Denver. | RenovoDerm features PHOENIX Wound Matrix and ANTHEM Wound Matrix at SAWC Fall, October 29-31, 2021. | M. Mark Melin, MD, FACS, RPVI MHealth Fairview, MN speaks about the value of PHOENIX Wound Matrix during the Innovative Technology podium presentation at SAWC Fall, October 29-31, 2021.
RenovoDerm-Phoenix-Wound-Matrix
Phoenix Wound Matrix is a 3D electrospun synthetic polymer matrix designed to improve wound healing outcomes by addressing chronicity and persistent inflammation for the management of acute and chronic wounds, and burns.

Biomimetic, synthetic, electrospun scaffolds provide the starting point for in situ tissue engineering (TE).

In situ TE is defined as biomaterial-induced endogenous regeneration directly in the tissue's functional site starting from a resorbable device that gradually transforms into an autologous, homeostatic replacement tissue with the ability to repair, remodel, and grow (Wissing, et al, 2017).

The approach of in situ TE is built on the notion that the natural inflammatory response can be harnessed to induce endogenous tissue regeneration. The resorbable immunomodulatory scaffold provides a temporary microenvironment, which functions as an instructive road map for endogenous cells to infiltrate and create new, living, and functional tissue. It is hypothesized that, upon implantation, the scaffold provides support for mature tissue formation and adequate mechanical properties to withstand the hemodynamic loads. Over time, the scaffold should slowly resorb, ultimately resulting in a purely biological structure which has the ability to repair, remodel, and grow.

- Wissing et al, doi:10.1038/s41536-017-0023-2

Research

Our technology parent company, Nanofiber Solutions, is a medical device company with over 10 years experience using a proven technology and manufacturing approach to create unique, proprietary devices, like the Phoenix Wound Matrix, to effectively address heretofore unmet clinical needs.

Learn More
Download

Application Guide

For more information about how to apply the Phoenix Wound Matrix, click the link below to download our application guidelines.

Learn More

Reimbursement

For information on reimbursement payment and coding information for the Phoenix Wound Matrix, click the link below.

Learn More
RenovoDerm-Phoenix-What-Is-Phoenix-Wound-Matrix

Indications for use:

  • Partial and full-thickness wounds
  • Pressure ulcers
  • Venous ulcers
  • Diabetic ulcers
  • Trauma wounds
    1. Abrasions
    2. Lacerations
    3. Second degree burns
    4. Skin tears
    5. Draining wounds
  • Chronic vascular ulcers
  • Tunneled/undermined wounds
  • Surgical wounds
    1. Donor sites/grafts
    2. Post-Moh's surgery
    3. Post laser surgery
    4. Podiatric
    5. Wound dehiscence


Acknowledgement:

Information on reimbursement in the United States is provided as a courtesy. Due to the rapidly changing nature of the law and Medicare payment policy, and our reliance on information provided by outside sources, the information provided herein does not constitute a guarantee or warranty by RenovoDerm, Inc. that reimbursement will be received. This information is provided "AS IS" and without any other warranty or guarantee, expressed or implied, as to completeness or accuracy or otherwise. This information has been compiled based on data gathered from many primary and secondary sources, including the American Medical Association and certain Medicare contractors.